SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NTTG who wrote (12394)9/9/2013 11:46:57 AM
From: Howard Williams  Read Replies (1) | Respond to of 13111
 
>>it is the only path to potential approval<<

Really? That means you are certain BTD or AA are out of the question. I wasn't aware you have direct contact with the FDA on this matter. Fascinating.



To: NTTG who wrote (12394)9/9/2013 11:56:28 AM
From: Mimbari  Read Replies (1) | Respond to of 13111
 
I said they already know the likely outcome. Observation of the data from the comparative drugs shows this. They run trials too and their results are public. It's not hard to figure out what is going to happen.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News